MedPath

Smartphone Intervention for Subthreshold Depression

Not Applicable
Completed
Conditions
Subthreshold Depression
Interventions
Device: Smartphone Application
Registration Number
NCT03110016
Lead Sponsor
Kibi International University
Brief Summary

The study aimed to examine the feasibility, usability, user satisfaction, safety, and preliminary efficacy of a smartphone application intervention for young adults with subthreshold depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Aged 18-24 years
  • Has a Center for Epidemiologic Studies Depression Scale score of ≥16
  • Owns a smartphone with the iOS® operating system
Exclusion Criteria
  • Lifetime history of major depressive disorder
  • Lifetime history of bipolar disorder
  • Currently receiving treatment for a mental health problem from a mental health professional
  • Experience of a major depressive episode in the 2 weeks prior to the study, as ascertained using the Mini-International Neuropsychiatric Interview

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Smartphone ApplicationSmartphone ApplicationSPSRS is a smartphone application system designed to improve self-confidence in individuals with subthreshold depression. The application presents a motion picture that displays words every 5 s for improving self-confidence of the user.
Primary Outcome Measures
NameTimeMethod
Feasibility, as measured by adherence to the smartphone application intervention.5 weeks after initiating the intervention

Adherence is calculated as the number of minutes in a week for which the participant uses the SPSRS application divided by the recommended weekly duration (70 min).

Secondary Outcome Measures
NameTimeMethod
Usability and user satisfaction5 weeks after initiating the intervention

USE Questionnaire

Number of participants with treatment-related adverse events as assessed by Mini-International Neuropsychiatric Interview.baseline and 1, 2, 3, 4, and 5 weeks after initiating the intervention

Mini-International Neuropsychiatric Interview

Depressive symptomsbaseline and 5 weeks after initiating the intervention

Center for Epidemiologic Studies Depression Scale score

Inflammatory biomarkerbaseline and 5 weeks after initiating the intervention

Level of salivary interleukin-6

General self-efficacybaseline and 5 weeks after initiating the intervention

General Self-Efficacy Scale score

Social anxietybaseline and 5 weeks after initiating the intervention

Liebowitz Social Anxiety Scale score

Mental healthbaseline and 5 weeks after initiating the intervention

12-item General Health Questionnaire score

Trial Locations

Locations (1)

Kibi International University

🇯🇵

Takahashi, Okayama, Japan

© Copyright 2025. All Rights Reserved by MedPath